Press-release for stocks

Prices are updated after-hours

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
Published: 2022-01-04 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K

| 67.47% | O: 61.79% H: 53.51% C: 14.04%
alzheimer therapeutics disease positive results positive results alzheimer’s alzheimer's disease alzheimer's ht-alz

Hoth Therapeutics Announces Positive Phase 1b Results for Completed First Cohort of Patient Trial of BioLexa
Published: 2021-09-08 (Crawled : 12:00) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K

| -11.94% | O: -1.49% H: 1.52% C: 1.52%
phase 1 positive results trial phase 1b phase 2b

| -20.81% | O: 0.67% H: 0.67% C: -3.33%
treatment acne potential positive results

| -25.79% | O: 1.26% H: 4.97% C: -1.86%
treatment phase 1 positive results dermatitis trial atopic dermatitis phase 1b al001 adi-001 phase 2b

67%

33%

AGBA | News | $1.26 215.0% 68.25% 130M

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

NVFY | $2.77 31.28% 23.83% 33M

ZCMD | $1.87 28.97% 22.46% 31M

RCON | $0.1112 13.01% 21.28% 1.7M

INSG | $3.03 25.21% 20.13% 330K

GCTK | $0.8191 22.25% 18.2% 190K

WLGS | $0.59 18.0% 17.9% 2.3M

ASNS | $0.828 21.75% 17.86% 18K

Save your searches and get alerts when important news are released.